Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
DNA Vaccines: History, Molecular Mechanisms and Future Perspectives.
Pagliari S. et al, (2023), Journal of molecular biology, 435
An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.
Dold C. et al, (2023), Science translational medicine, 15
Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines.
Dold C. et al, (2023), Vaccine, 41, 3047 - 3057
Regulatory T cell profiles in patients with N-methyl-ᴅ-aspartate receptor-antibody encephalitis.
Iro MA. et al, (2023), Encephalitis (Seoul, Korea), 3, 15 - 23
Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation
Rollier CS. et al, (2022), Vaccine, 40, 4453 - 4463
Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial.
Rollier CS. et al, (2022), mSphere, 7
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Barrett JR. et al, (2021), Nature Medicine, 27, 1113 - 1113
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Ahern DJ. et al, (2021)
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Barrett JR. et al, (2021), Nature Medicine, 27, 279 - 288
MAIT cell activation augments adenovirus vector vaccine immunogenicity
Provine NM. et al, (2021), Science, 371, 521 - 526
Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule
Rollier CS. et al, (2020), Scientific Reports, 10
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
Ainsworth M. et al, (2020), The Lancet Infectious Diseases, 20, 1390 - 1400
Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine
O’Connor D. et al, (2020), Molecular Systems Biology, 16
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478
Publisher Correction: Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria.
Milicic A. et al, (2019), Scientific reports, 9
Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis.
Awanye AM. et al, (2019), Scientific reports, 9
Heterogeneous early immune responses to the S. aureus EapH2 antigen induced by gastrointestinal tract colonisation impact the response to subsequent vaccination
Flaxman A. et al, (2019), Vaccine, 37, 494 - 501
Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease
Elshina E. et al, (2019), Vaccine, 37, 502 - 509